Detailed Information on Publication Record
2022
Percutaneous Endoluminal Radiofrequency Ablation of Occluded Biliary Metal Stent in Malignancy Using Monopolar Technique: A Feasibility Study
ROHAN, Tomáš, Tomáš ANDRAŠINA, Peter MATKULČÍK, Vladan BERNARD, Vlastimil VÁLEK et. al.Basic information
Original name
Percutaneous Endoluminal Radiofrequency Ablation of Occluded Biliary Metal Stent in Malignancy Using Monopolar Technique: A Feasibility Study
Authors
ROHAN, Tomáš (203 Czech Republic, guarantor, belonging to the institution), Tomáš ANDRAŠINA (703 Slovakia, belonging to the institution), Peter MATKULČÍK (703 Slovakia, belonging to the institution), Vladan BERNARD (203 Czech Republic, belonging to the institution) and Vlastimil VÁLEK (203 Czech Republic, belonging to the institution)
Edition
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, NEW YORK, SPRINGER, 2022, 0174-1551
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30224 Radiology, nuclear medicine and medical imaging
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.900
RIV identification code
RIV/00216224:14110/22:00125706
Organization unit
Faculty of Medicine
UT WoS
000761841200001
Keywords in English
Biliary malignancy; Biliary stenosis; Intraductal ablation; Metal stent; Monopolar technique; Radiofrequency ablation
Tags
International impact, Reviewed
Změněno: 20/1/2023 10:46, Mgr. Tereza Miškechová
Abstract
V originále
Purpose: To prove feasibility and safety of percutaneous endoluminal radiofrequency ablation (eRFA) using a monopolar approach in treatment of occluded biliary stent in malignancy. Materials and Methods: The study included 11 patients with occluded biliary metal stent that had been implanted due to malignant biliary obstruction. All underwent metal stent recanalization by percutaneous eRFA in monopolar setting. Sixteen eRFA procedures were performed under fluoroscopic guidance with an EndoHPB 8F radiofrequency ablation catheter. The effect of stent recanalization was assessed based upon change from pre- to post-procedural diameter of the patent lumen of the metal stent (Wilcoxon test), primary and secondary stent patency (compared by log-rank test), catheter-free period, and overall survival. Adverse events were evaluated according to Common Terminology Criteria for Adverse Events (CTCEA) 4.0. Results: Recanalization of the metal stent by monopolar radiofrequency ablation was successful in all 11 patients. Diameter of the patent lumen of the stent significantly widened after the eRFA inside the stent (median 2 vs. 7 mm, p = 0.003). Grade 1 complications were observed in one-third of procedures. Median stent patency after recanalization by eRFA was non-inferior to primary metal stent patency (154 vs. 161 days, p = 0.27). Median catheter-free survival and overall survival after stent recanalization were 149 and 210 days, respectively. Conclusion: Endoluminal radiofrequency ablation in monopolar setting was shown to be a feasible and safe method for recanalization of occluded biliary metal stents.
Links
MUNI/A/1388/2021, interní kód MU |
| ||
NU21-08-00561, research and development project |
|